FDA ISSUES RECOMMENDATIONS TO REDUCE THE RISK FOR ZIKA VIRUS BLOOD TRANSMISSION IN THE UNITED STATES
As a safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection.